Literature DB >> 32043657

miR-155 overexpression is followed by downregulation of its target gene, NFE2L2, and altered pattern of VEGFA expression in the liver of melanoma B16-bearing mice at the premetastatic stage.

Mariya B Aksenenko1, Nadezhda V Palkina1, Olga N Sergeeva1, Ekaterina Yu Sergeeva1, Andrey K Kirichenko2, Tatiana G Ruksha1.   

Abstract

MicroRNAs are involved in the control of tumour progression and in metastatic cascade dynamics. However, the role of microRNAs in distant organ reorganization at the premetastatic stage is less clear, although the process of premetastatic niche formation is a crucial event according to modern concepts of tumour dissemination. The role of the present study was to investigate the expression levels of miR-155, miR-21, miR-205 and miR-let7b, as well as that of their target genes, in target organs of melanoma metastasis at the premetastatic stage. The expression levels of both the pro-oncogenic miR-155 and the tumour suppressive miR-205 were found to be altered in the premetastatic liver of melanoma B16-bearing mice. Bioinformatics analysis identified the target genes of miR-155 to be nuclear factor, erythroid 2 like 2 (NFE2L2), secretogranin II, miR-205, semaphorin 5A and vascular endothelial growth factor A (VEGFA). Among those, the redox status regulatory factor NFE2L2 was downregulated, which corresponded to increased levels of miR-155. Due to the ability of pro-oxidative events to initiate angiogenesis, VEGFA levels were evaluated in the premetastatic liver by immunohistochemistry, which revealed increased VEGFA expression in the central parts of the organ and diminished expression in the periphery. Taken together, these findings may support the concept of functional organ reorganization due to melanoma progression.
© 2020 The Authors. International Journal of Experimental Pathology © 2020 International Journal of Experimental Pathology.

Entities:  

Keywords:  erythroid 2 like 2; melanoma; metastasis; miR-155; miR-205; nuclear factor; vascular endothelial growth factor A

Mesh:

Substances:

Year:  2020        PMID: 32043657      PMCID: PMC7042756          DOI: 10.1111/iep.12342

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  49 in total

Review 1.  Role of microRNAs in stem/progenitor cells and cardiovascular repair.

Authors:  Philipp Jakob; Ulf Landmesser
Journal:  Cardiovasc Res       Date:  2011-12-01       Impact factor: 10.787

2.  Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p.

Authors:  Ting He; Feifei Qi; Lin Jia; Shan Wang; Chunying Wang; Nan Song; Yan Fu; Lin Li; Yongzhang Luo
Journal:  Cancer Lett       Date:  2015-08-10       Impact factor: 8.679

3.  Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis.

Authors:  Scott Valastyan; Nathan Benaich; Amelia Chang; Ferenc Reinhardt; Robert A Weinberg
Journal:  Genes Dev       Date:  2009-10-29       Impact factor: 11.361

4.  Proteomic characterization of early lung response to breast cancer metastasis in mice.

Authors:  Anna Kurpińska; Joanna Suraj; Emilia Bonar; Agnieszka Zakrzewska; Marta Stojak; Magdalena Sternak; Agnieszka Jasztal; Maria Walczak
Journal:  Exp Mol Pathol       Date:  2019-02-11       Impact factor: 3.362

Review 5.  Characteristics and Significance of the Pre-metastatic Niche.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cancer Cell       Date:  2016-11-14       Impact factor: 31.743

6.  MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling.

Authors:  William W Du; Ling Fang; Minhui Li; Xiangling Yang; Yaoyun Liang; Chun Peng; Wei Qian; Yunxia Q O'Malley; Ryan W Askeland; Sonia L Sugg; Jun Qian; Jiang Lin; Zide Jiang; Albert J Yee; Michael Sefton; Zhaoqun Deng; Sze Wan Shan; Chia-Hui Wang; Burton B Yang
Journal:  J Cell Sci       Date:  2013-02-15       Impact factor: 5.285

Review 7.  Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.

Authors:  Kaushala Jayawardana; Sarah-Jane Schramm; Varsha Tembe; Samuel Mueller; John F Thompson; Richard A Scolyer; Graham J Mann; Jean Yang
Journal:  J Invest Dermatol       Date:  2016-01       Impact factor: 8.551

8.  Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer.

Authors:  Gert G Van den Eynden; Steven J Van Laere; Ilse Van der Auwera; Leen Gilles; J Lance Burn; Cecile Colpaert; Peter van Dam; Eric A Van Marck; Luc Y Dirix; Peter B Vermeulen
Journal:  Clin Exp Metastasis       Date:  2007-02-13       Impact factor: 4.510

9.  Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.

Authors:  Anna Komina; Nadezhda Palkina; Mariya Aksenenko; Seseg Tsyrenzhapova; Tatiana Ruksha
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

10.  MIR155 Regulation of Ubiquilin1 and Ubiquilin2: Implications in Cellular Protection and Tumorigenesis.

Authors:  Sanjay Yadav; Nishant Singh; Parag P Shah; David A Rowbotham; Danial Malik; Ankita Srivastav; Jai Shankar; Wan L Lam; William W Lockwood; Levi J Beverly
Journal:  Neoplasia       Date:  2017-03-16       Impact factor: 5.715

View more
  4 in total

1.  miR-155 overexpression is followed by downregulation of its target gene, NFE2L2, and altered pattern of VEGFA expression in the liver of melanoma B16-bearing mice at the premetastatic stage.

Authors:  Mariya B Aksenenko; Nadezhda V Palkina; Olga N Sergeeva; Ekaterina Yu Sergeeva; Andrey K Kirichenko; Tatiana G Ruksha
Journal:  Int J Exp Pathol       Date:  2020-02-11       Impact factor: 1.925

2.  LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis.

Authors:  Jinlan Guo; Quan Gan; Caibin Gan; Xiaoning Zhang; Xinping Ma; Mingliang Dong
Journal:  Aging (Albany NY)       Date:  2021-02-01       Impact factor: 5.682

Review 3.  SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia.

Authors:  Elisabetta Valentini; Marta Di Martile; Donatella Del Bufalo; Simona D'Aguanno
Journal:  J Exp Clin Cancer Res       Date:  2021-04-15

Review 4.  The Hepatic Pre-Metastatic Niche.

Authors:  Benjamin Ormseth; Amblessed Onuma; Hongji Zhang; Allan Tsung
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.